在流感疫苗抗体建模中,探索由于检测极限值以下的偏差:CIVIC研究的案例研究和指导指南

相关实验视频

Updated: Jul 8, 2026

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Published on: April 4, 2011

Yang Ge¹, Andreas Handel², Philippe J Giabbanelli³

¹College of Public Health, The University of Georgia, Athens 30606, GA, USA.

|February 5, 2025

概括

实验室测定中缺失的值在疫苗血凝抑制 (HAI) 测试中很常见,可能会扭曲结果. 这项研究引入了一种使用间隔审查的新方法,以准确地模拟疫苗HAI标位增加,减少标准归算技术的偏差.

科学领域:

免疫学和疫苗学免疫学和疫苗学
生物统计学和数据科学

背景情况:

由于检测极限 (LOD) 的缺失值在实验室测定数据集中普遍存在,包括用于疫苗评估的血液凝结抑制 (HAI) 测定.
标准的归算方法,例如将值重新编码为LOD或LOD/2,可以引入偏差,并在研究中导致错误的重要发现.
准确建模疫苗HAI标量增加对于了解疫苗的疗效和开发至关重要.

研究的目的:

为了研究在模拟疫苗HAI标位增加时,标准归算方法引入的偏差.
开发和评估一种使用间隔审查来调整参数估计偏差的修改模型方法.
为未来的疫苗研究提供一个案例研究和指南,涉及审查的HAI数据.

主要方法:

使用CIVIC-UGAFLUVAC血液凝结抑制试验 (HAI) 数据集,探索模拟疫苗HAI标位增加中的偏差.
修改了标位增加建模方法,以整合一个间隔审查框架.
拟议的间隔审查方法与标准归算技术之间的参数估计偏差的比较.

主要成果:

在HAI测试中处理检测极限 (LOD) 值的标准归算方法可能会导致偏差的参数估计.
使用间隔审查的修改模型方法表明,与标准归算相比,参数估计的偏差减少了.
拟议的方法提供了一个更统计合理的方法来分析疫苗HAI标位数据与受审查的值.

结论:

对被审查数据的准确统计处理,特别是在检测的极限,对于可靠的疫苗疗效研究至关重要.
间隔审查为模拟疫苗HAI标位增加提供了比标准归算方法更少偏见的替代方案.
这项研究为未来的疫苗研究提供了有价值的方法框架,该研究涉及审查的实验室测试数据.

关键词:

哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈流感是一次流感.这是一个 LOD LOD LOD.检测的检测极限疫苗疫苗疫苗疫苗

更多相关视频

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

相关概念视频

Bias

Bias

Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Bias in Epidemiological Studies

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is: